Amivantamab

Index terms

Amivantamab

Sibling codes

XM0AN7 – Oportuzumab monatox
XM2KA7 – Retifanlimab
XM3Q80 – Tislelizumab
XM5Q93 – Sacituzumab govitecan

Foundation entity

Amivantamab – http://id.who.int/icd/entity/1329632950

Part of: XM9ND9: Programmed cell death protein 1/death ligand 1 inhibitors › XM1JG6: Monoclonal antibodies and antibody drug conjugates › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes